IGC Pharma, Inc. IGC
Set alert
0.19 USD -0.01 -7.13%
At close · Oct 30
0.19 0.00 +2.00%
After hours · Oct 30, 7:59 PM ET
0.1808 Day range 0.197
0.185 52-week range 0.40
- YTD
- -33.93%
- 1 year
- -53.75%
- Open
- 0.191
- Prev close
- 0.1992
- Mkt cap
- 19.13M
- Vol
- 523.10K
- Avg vol
- 747.28K
- EPS
- -0.07
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1808
- High
- 0.197
- Forward P/E
- -3.74
- Beta
- 1.29
- Short ratio
- 2.29
- Inst. own
- 22.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 12, 2025
- 50-d avg
- 0.3768
- 200-d avg
- 0.421
- 1y target
- 3.75
MAX chart
Events in this range
- Sep 3, 2024Rating: Ascendiant Capital · Buy → Buy
- Dec 5, 2024Rating: Ascendiant Capital · Buy → Buy
Signals (69)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Nov 1, 2025 | 1 year ago |
| SMA: Bearish | Nov 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Oct 1, 2024 | 2 years ago |
| SMA: Bearish | Oct 1, 2024 | 2 years ago |
| SMA: Bullish | Sep 1, 2024 | 2 years ago |
| SMA: Bullish | Sep 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 1, 2024 | 2 years ago |
| SMA: Bearish | Jun 1, 2024 | 2 years ago |
| SMA: Bullish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Feb 1, 2024 | 2 years ago |
| SMA: Bearish | Oct 1, 2023 | 3 years ago |
| SMA: Bullish | Aug 1, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 1, 2023 | 3 years ago |
| SMA: Bearish | Dec 1, 2021 | 4 years ago |
| MACD: Sell Signal | Oct 1, 2021 | 5 years ago |
| SMA: Bearish | Aug 1, 2021 | 5 years ago |
| SMA: Bullish | Jun 1, 2021 | 5 years ago |
| SMA: Bearish | May 1, 2021 | 5 years ago |
| SMA: Bullish | Nov 1, 2020 | 6 years ago |
| SMA: Bearish | Sep 1, 2020 | 6 years ago |
| MACD: Buy Signal | Sep 1, 2020 | 6 years ago |
| SMA: Bullish | Aug 1, 2020 | 6 years ago |
| SMA: Bullish | Aug 1, 2020 | 6 years ago |
| MACD: Sell Signal | May 1, 2019 | 7 years ago |
| SMA: Bearish | Apr 1, 2019 | 7 years ago |
| SMA: Bullish | Feb 1, 2019 | 7 years ago |
| SMA: Bullish | Feb 1, 2019 | 7 years ago |
| MACD: Buy Signal | Feb 1, 2019 | 7 years ago |
| MACD: Sell Signal | Jan 1, 2019 | 7 years ago |
| SMA: Bearish | Nov 1, 2018 | 8 years ago |
| SMA: Bearish | Oct 1, 2018 | 8 years ago |
| SMA: Bullish | Aug 1, 2018 | 8 years ago |
| SMA: Bullish | Aug 1, 2018 | 8 years ago |
| RSI: Overbought | Aug 1, 2018 | 8 years ago |
| SMA: Bearish | Jul 1, 2018 | 8 years ago |
| SMA: Bearish | Mar 1, 2018 | 8 years ago |
| SMA: Bullish | Oct 1, 2017 | 9 years ago |
| SMA: Bullish | Sep 1, 2017 | 9 years ago |
| SMA: Bearish | Aug 1, 2017 | 9 years ago |
| SMA: Bearish | Aug 1, 2017 | 9 years ago |
| SMA: Bullish | Mar 1, 2017 | 9 years ago |
| SMA: Bullish | Mar 1, 2017 | 9 years ago |
| SMA: Bearish | Nov 1, 2016 | 10 years ago |
| SMA: Bullish | Feb 1, 2016 | 10 years ago |
| SMA: Bearish | Aug 1, 2014 | 12 years ago |
| SMA: Bullish | May 1, 2014 | 12 years ago |
| SMA: Bearish | Jun 1, 2013 | 13 years ago |
| SMA: Bullish | Feb 1, 2013 | 13 years ago |
| SMA: Bearish | May 1, 2012 | 14 years ago |
| SMA: Bullish | Feb 1, 2012 | 14 years ago |
| SMA: Bearish | May 1, 2010 | 16 years ago |
| SMA: Bullish | Apr 1, 2010 | 16 years ago |
| SMA: Bearish | Feb 1, 2010 | 16 years ago |
| MACD: Buy Signal | Oct 1, 2009 | 17 years ago |
| SMA: Bullish | Jul 1, 2009 | 17 years ago |
| RSI: Oversold | Oct 1, 2008 | 18 years ago |
| RSI: Oversold | Mar 1, 2008 | 18 years ago |
| SMA: Bearish | Feb 1, 2008 | 18 years ago |
| SMA: Bullish | Nov 1, 2007 | 19 years ago |
| SMA: Bearish | Oct 1, 2007 | 19 years ago |
| SMA: Bullish | Sep 1, 2007 | 19 years ago |
| SMA: Bearish | Aug 1, 2007 | 19 years ago |
Financial health
Altman Z-Score
-18.60 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 2
Valuation
P/E -3.6×
FY 2017 5y median -3.1× FY 2026
P/S 21.1×
FY 2017 5y median 20.8× FY 2026
P/B 4.1×
FY 2017 5y median 3.4× FY 2026
P/FCF -4.1×
FY 2017 5y median -4.1× FY 2026
EV/EBITDA -4.0×
FY 2017 5y median -2.6× FY 2026
EV/Sales 21.7×
FY 2017 5y median 20.2× FY 2026
FCF Yield -24.4%
FY 2017 5y median -24.2% FY 2026
Profitability
Gross Margin 29.7%
FY 2017 5y median 48.7% FY 2026
Operating Margin -860.3%
FY 2017 5y median -860.3% FY 2026
Net Margin -552.1%
FY 2017 5y median -966.5% FY 2026
ROE -107.0%
FY 2017 5y median -107.0% FY 2026
ROIC -144.8%
FY 2017 5y median -113.0% FY 2026
ROA -71.3%
FY 2017 5y median -71.3% FY 2026
Growth (YoY)
Revenue -6.7%
FY 2017 FY 2026
Operating Income -37.0%
FY 2017 FY 2026
EPS (diluted) 22.3%
FY 2017 FY 2026
Free Cash Flow -15.7%
FY 2017 FY 2026
Financial Health
Current Ratio 0.4×
FY 2017 5y median 1.6× FY 2026
Quick Ratio 0.2×
FY 2017 5y median 0.9× FY 2026
Debt / Equity 0.2×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA -0.1×
FY 2017 5y median 0.1× FY 2026
Interest Coverage 0.0×
FY 2017 5y median 0.0× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-03-31